Connect with us

Health & Society

Xylazine, a one-way trip to Dante’s Inferno

Published

on

In the whole world, environmental disasters, poverty, inequalities and social injustice are increasing, health care is degrading, same for education and moral values; it is also noted the instrumentalisation of religions and human rights; the metropoles are subject to pollution, crimes, human trafficking and flourishing illicit drug markets. And among the long, impressive and life-threatening list of illicit drugs and New Psychoactive Substances (NPS) -most often produced to circumvent the drug laws- the emergence of a new one, Xylazine, is gaining the attention of the concerned authorities (Rodriguez N. et al., 2008).Xylazine is making the deadliest drug threat our country has ever faced, fentanyl, even deadlier,” said Administrator Milgram-U.S.A. Drug Enforcement Administration (2023).

The xylazine (C12H16N2S) is not an opioid like fentanyl but a methyl benzene from the class of phenothiazines. It had been produced by various alternate syntheses, starting in Germany (Bayer Pharmaceutics, 1962). This is a highly lipophilic substance, so easily crosses the membranes and reaches the brain receptors as well as the ones in the body.

This is a drug initially considered for use in humans as an antihypertensive agent, but due to the adverse effects in humans (severe hypotension and Central Nervous System depressant effects), its medical use was discontinued.

In 1972 its use was approved by the U.S. Food and Drug Administration only in veterinary medicine for sedation (for 1-4 hours), analgesia (15-30 min), anaesthesia for surgical procedures, and as a muscle relaxant, in animals such as horses, cattle, sheep, dogs, and others.

Xylazine in human misuse is known under the names of flesh-eating drug, tranq, tranq-dope, zombie drug, sleep-cut, and Philly dope. It is called a “zombie drug” because the users have this particular, confused, hunched and slowed move or in some cases are in a trance-like state, which gives them the appearance of the living dead that people describe as being zombie-like.

In 2022, the Estonian police reported seizing mixtures containing new opioids and the animal sedative and analgesic xylazine. Most often, xylazine is used as a cheap drug adjuvant (online, for 6-20 dollars per kilogram) to inflate doses of hard drugs, including the opioid fentanyl whose mixture is health devastating. The first death in Europe associated with xylazine use was reported in England (UK) in 2022 with a postmortem detection of heroin, cocaine, fentanyl, and xylazine (Rock K. L. et al., 2023).

As an illicit drug, xylazine can be consumed orally, by smoking, snorting, by intramuscular, subcutaneous, or intravenous injection. The drug’s reported duration of effect is longer than that of fentanyl. The adulteration of fentanyl with xylazine allows to extend the feeling of euphoria and analgesia induced by fentanyl and to reduce the frequency of injections (Gupta R. et al. 2023).

Xylazine would be 50 times more powerful than heroin, and 100 times more powerful than morphine. Xylazine is currently responsible for a third of overdose deaths in the United States. Indeed, the Centers for Disease Control and Prevention, Report 30 (June 2023), mentions that the number of drug overdose deaths involving xylazine was 102 in 2018, 627 in 2019, 1 499 in 2020, and 3 468 in 2021.

In users, xylazine causes loss of consciousness, and states of stupor and in injecting users can lead to skin lesions, and ulcers that, easily infected, can cause gangrene and necrosis often requiring amputation to remove the limb with the rotting tissue. The Professor of Neurobiology S. Kourrich (2023) speaks of the devastating effects, beyond addiction, of xylazine on health, including skin lesions worthy of horror movies.

The signs and symptoms of xylazine overdose are similar to those of heroin, fentanyl, and other opioids. When xylazine is added to opioids, severe toxicity and death can occur due to the combined effects of the drugs. But, because xylazine is not an opioid, Naloxone (best antidote for opioid overdose – Jordan M.R. and Morrissonponce D., 2023) is unlikely to be effective in treating people. There is no safe xylazine drug dose to use!

Xylazine acts within the brain to cause sedation and abnormally slow breathing, a life-threatening respiratory depression (that can request tracheostomy) leading to cardiac arrest and death. The effects of severe xylazine intoxication can last for several days.

Xylazine is an adrenergic agonist, having the same action as adrenaline, a hormone and neurotransmitter (Chavez-Arias et al., 2014). Due to its highly lipophilic nature, xylazine directly stimulates the Central Nervous System alpha(α)2-adrenergic receptors as well as other peripheral α-adreno receptors in a great variety of tissues. It has been shown that the human placenta expresses α2-adrenergic receptors that may be implicated in pathogenesis and fetal growth restriction (Motawea H.K.B. et al., 2018).

Note: The 5 main different types of adreno-receptors are:

(Alpha) α-1: present on the smooth muscle fibres of the vessels; α-2: pre-synaptic localization (inhibitory effect on the synapse) located in the central nervous system and heart. α-2 is composed of 3 subtypes A, B, C.

(Beta) β-1: present in the heart where it strengthens the activity (faster and stronger beats); β-2: present locally on certain tissues and allows vasodilation of the arteries or dilation of the bronchi; β-3: present on adipocytes, stimulates thermogenesis.

These receptors are a class of G protein-coupled receptors, a family of transmembrane receptors in mammals, target of many catecholamines as the natural ligands of the α2-receptors which are: the noradrenaline (norepinephrine) which has a greater affinity, the adrenaline (epinephrine), and the dopamine (the molecule of pleasure, part of the reward system in the brain).

Xylazine inhibits the release of both neurotransmitters dopamine and norepinephrine at the neuronal synapse, resulting in depression of the Central Nervous System interfering with behavioural flexibility, working memory, and nociceptive control and it causes the inhibition of the Sympathetic Nervous System (automatic activities of the body) as on smooth muscle contraction and at heart level a bradyarrhythmia, thus responsible for the decrease of alertness, nociception, muscle tone and of the fight-or-flight response.

Xylazine is metabolized in the liver by the cytochrome P450 enzymes, and then 70% is excreted as urine (Barroso M. et al., 2007). So, urine can be used in detecting xylazine through its metabolites but within a few hours, they decrease to undetectable levels.

How come people are voluntarily reaching such a point of self-destruction, debilitating and painful physical deterioration and dependence?

Substance abuse (greed and dependence) has been associated with early emotional deficiencies resulting in an inability to tolerate emotions and regulate self-esteem and relationships with others (Krystal H., 1982).

Before reaching this addiction point there is a long way to go, starting often with alcohol and cannabis (and some medicines). It is not with legalization, decriminalisation, or shooting rooms that the drug problem will be solved, these ways appear to escape the responsibilities in terms of prevention.

Even if there is no ideal age to talk about the harmful effects of drug use, young people must be informed of these risks as early as possible. The role of the parents -when it is not itself a risk factor- by listening, conversing and providing correct information remains the best prevention. This should be reinforced by trained teachers and educators with continuous yearly teaching adapted to the age and with prevention actions carried out by governments, communities, organizations and associations, among youth and parents.

This is what the Say No To Drugs volunteers across Europe with the Foundation for a Drug-Free Europe strive to achieve through the educational materials The Truth About Drugs*.

The Greek philosopher Epictetus (50-135 A.D.) said: Only the educated are free. Indeed, education provides awareness and knowledge of basic elements of life and gives the ability to differentiate the right from the wrong and to take the right decision. Because as said by the humanist L. Ron Hubbard in 1956: It’s a problem in unawareness. The ethics, the morality, the capability of good, sound judgment alike depend upon the ability to be aware.

Instead of living the drug hell torments of a drug addict who can no longer stand life enslaved to the increasing spiral of harmful drug doses, isn’t it better to be able to face life responsibly, and freely, and act with passion and perseverance to make dreams come true?

REFERENCES

www.emcdda.europa.eu/publications/european-drug-report/2023/

www.desdiversion.usdoj.gov/drug_chem_info/Xylazine.pdf

www.poison.org/articles/what-is-xylazine

https://www.cdc.gov/nchs/data/vsrr/vsrr030.pdf

https://www.dea.gov/alert/dea-reports-widespread-threat-fentanyl-mixed-xylazine

(*)Visit:

  • wwwdrugfreeworld.org (free materials in 20 languages)
  • Foundation for a Drug-Free Europe: https://fdfe.eu

Author

Health & Society

EU treading Dangerous Waters: The Perils of Psychedelics in Therapeutic Use

Published

on

The European Commission is getting ready to review citizens’ proposals and one controversial idea on the table is the ‘PsychedeliCare’ initiative that supports the exploration and implementation of psychedelic treatments for mental wellbeing issues. Advocates of this initiative highlight the advantages of using psychedelics in addressing mental health concerns; however it’s crucial to carefully assess the consequences of making these substances mainstream for therapeutic use, it already happened with way too many “pharma products” and end up being dangerous street drugs, as this is what they actually were from the beginning.

The Illusory Promise of Psychedelics

Supporters of this “therapies” frequently promote these substances as amazing remedies for profound mental health challenges like depression and anxiety disorders such as PTSD are regularly highlighted by them in support of their claims. However, these early research findings are willfully misinterpreted and exaggerated. The “positive outcomes” observed in limited research studies do not automatically translate to safety and effectiveness across wider and more varied demographic groups, often the contrary. Throughout history the fascination with a quick fix for mental health issues has often resulted in disappointment and harm, if not death.

A Lack of Comprehensive Understanding

The insufficient scientific knowledge about psychedelics raises concerns within the community as the intricate workings of the human brain remain a mystery when influenced by these substances. There are risks such as psychological distress and worsening of preexisting mental health conditions that make it unthinkable to integrate psychedelics into mainstream therapy practices at all. It is crucial to acknowledge the variations in individual experiences and biological compositions to prevent unintended harm rather than aiding in treatment efforts.

Regulatory and Ethical Concerns

The push for government endorsement of psychedelic therapies raises numerous ethical questions. Should substances with known psychoactive properties be part of mainstream health care? The regulatory environment surrounding these compounds is fraught with challenges, including ensuring quality control, standardizing dosages, and preventing misuse. With the legalization movements in various regions, the potential for recreational abuse expands, risking public health and safety.

Historical Context and Social Implications

Looking back, the late 1960s and early 1970s were marked by a psychedelic counterculture that resulted in societal turmoil and increased drug abuse. The legacy of this era still looms large; many young individuals romanticize psychedelic use without regarding the severe consequences that accompanied its earlier popularity, including addiction, mental health crises, and a societal disregard for safety protocols.

A Dangerous Precedent

By calling for a more prominent role for psychedelics in treatment protocols, the advocates of the ‘PsychedeliCare’ initiative may unintentionally set a dangerous precedent. Replacing established, evidence-based treatments with unproven psychedelic therapies could detract from the very real progress made in mental health care. It could shift focus away from holistic approaches that consider lifestyle, therapeutic counseling, and medication tailored to individual needs.

Conclusion

The debate surrounding the ‘PsychedeliCare’ initiative should prompt a vigilant and cautious examination of the implications of endorsing psychedelics as treatment options. While there is a critical need for innovative approaches in mental health care, rushing to embrace unproven therapies poses significant risks. It is paramount that we prioritize rigorous scientific scrutiny, ethical considerations, and the well-being of individuals over the allure of quick solutions. The only clear path forward is one grounded in proven therapies, comprehensive research, and unwavering commitment to public health.

Author

Continue Reading

Health & Society

Why chocolate should not be given to dogs

Published

on

Chocolate is a favorite delicacy for people, but for cats and dogs it is a real poison, writes the magazine ” Sciences et Avenir” and explains why pets should not be “pampered” with chocolate under any circumstances.

For them, chocolate is toxic, because it is not properly absorbed by their body. This is due to the alkaloid theobromine, which is contained in cocoa and therefore in chocolate.

The substance becomes dangerous to health when large amounts of it are stored in the liver. About 12 grams of theobromine are contained in dark chocolate, twice as much in milk chocolate, and very small amounts in white chocolate.

Theobromine does not harm humans, as the human body manages to break it down quickly.

However, it takes 20 hours for dogs to get rid of this molecule. It can build up in their liver and cause poisoning if large amounts of chocolate are ingested at once.

Among the symptoms are vomiting, diarrhea, rapid pulse, convulsions.

The same is true for cats. However, they are less attracted to chocolate than dogs because they cannot taste sweets with their tongues, although there are exceptions.

In addition, pet obesity is the subject of a number of educational campaigns aimed at owners.

A court in North West England has banned a British man from keeping pets for the next 10 years because his Dalmatian became too fat. wrote the English tabloid “Sun” in November 2009.

40-year-old man John Green, a resident of Macclesfield in Cheshire, showed extreme irresponsibility towards his dog Barney and fed him chips and chocolate.

Thus, in just three months, it became several times fatter than normal for its breed and reached 70 kg.

Green was tipped off by alarmed, vigilant fellow citizens.

Animal control officials warned Green that his dog’s health was in danger and recommended that he be put on a diet.

However, he did not follow the recommendations and the dog continued to gain weight.

The Dalmatian was eventually removed from his owner’s home in June and put on a diet in a private kennel, where staff made sure he got enough exercise.

As a result, Barney, who is eight years old, lost 40 kg.

Green pleaded guilty to causing his dog unnecessary suffering, but the court found some mitigating circumstances because the man treated Barney more like a friend than a dog and did not realize he was harming him.

That’s why Green was only sentenced to 200 hours of community service and to pay £780 in costs.

Illustrative Photo by Glenn: https://www.pexels.com/photo/high-angle-photo-of-a-corgi-looking-upwards-2664417/

Author

Continue Reading

Health & Society

Russian Orthodox Church calls on mass culture to abandon ‘images promoting alcoholism’

Published

on

On the occasion of the Day of Sobriety celebrated in the country today, the Russian Orthodox Church called on mass culture not to promote alcoholism, TASS reported.

The agency recalls that the All-Russian Day of Sobriety is celebrated on the initiative of the Russian Orthodox Church on September 11 to remind people of the harm caused by alcohol. On this day, in some parts of Russia, the sale of alcohol is limited or completely prohibited.

“The culture of attitude towards this is very important. There are many “nice jokes” about alcoholism in our everyday culture. There is nothing good about that. We know what the state of intoxication leads to. Those who deal with mass culture should make an effort that the image of the “dear drunkard” should still leave our mass culture,” said the head of the synodal department of the Moscow Patriarchate for Church Interaction on the sidelines of the St. Petersburg Forum of United Cultures with society and media Vladimir Legoida.

Asked whether it would be appropriate to ban or restrict the sale of alcohol across the country, he said “that would be wonderful”. “But it is important that people do this consciously, independently, not because someone is forcing them, and also that there is, as it is customary to say, a public consensus,” he stated.

Legoida noted that the category of “sobriety” is important for the church in general, which refers not only to abstinence from alcohol.

Meanwhile, during a press conference dedicated to the All-Russian Day of Sobriety, Russia’s Deputy Health Minister Oleg Salagai said that alcohol abuse can reduce a man’s life expectancy by six years and a woman by five years.

“The systemic measures that were adopted allowed us to really reduce alcohol consumption. Today, it can be confidently said that Russia is not one of the most drinking countries in the world,” said the deputy minister, who pointed out that in 2023 alcohol consumption in the country was about 8.4 liters per person, while at the beginning of the century the indicator was in double digits.

Illustrative Photo by EVG Kowalievska: https://www.pexels.com/photo/selective-focus-photography-of-assorted-brand-liquor-bottles-1128259/

Author

Continue Reading

Trending

Copyright © 2023 EuroTimes

Exit mobile version